doi: 10.3390/molecules25184320
Mishima E, Ito J, Wu Z, Nakamura T, Wahida A, Doll S, et al
Levocarnitine has been used in the treatment of primary and secondary carnitine deficiency in adults and neonates, Alzheimers disease, dilated cardiomyopathy in adults and children, valproic acid-induced hepatotoxicity in children, and hyperlipoproteinemia
The convenient delayed-release mechanism ensures that the medication is released at the optimum time, enhancing its efficacy while minimizing potential side effects
Since the first demonstration of nitric oxide generation in gastric mucosa which contributed to the antiulcer effect of BPC 157 in gastric lesion assay by Sikiric et al